Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/06/14/2899196/0/en/ASLAN-Pharmaceuticals-Announces-Plan-to-Implement-ADS-Ratio-Change.html
https://www.globenewswire.com/news-release/2024/05/21/2885431/0/en/ASLAN-Pharmaceuticals-Presents-Late-Breaking-Translational-Data-on-Eblasakimab-in-COPD-at-the-American-Thoracic-Society-International-Conference.html
https://www.globenewswire.com/news-release/2024/05/09/2878618/0/en/ASLAN-Pharmaceuticals-Reports-First-Quarter-2024-Financial-Results-and-Provides-Corporate-Update.html
https://www.globenewswire.com/news-release/2024/05/07/2876615/0/en/ASLAN-Pharmaceuticals-to-Present-Additional-Data-From-Interim-Analysis-of-TREK-DX-Phase-2-Study-of-Eblasakimab-in-Dupilumab-Experienced-Atopic-Dermatitis-Patients-During-Virtual-KO.html
https://www.globenewswire.com/news-release/2024/05/02/2874243/0/en/ASLAN-Pharmaceuticals-Announces-Expansion-of-its-Collaboration-With-Zenyaku-to-Investigate-the-Biology-Underlying-Differential-Effects-of-Eblasakimab-Compared-to-Other-Biologics.html
https://www.globenewswire.com/news-release/2024/04/30/2872039/0/en/ASLAN-Pharmaceuticals-to-Host-KOL-Panel-Discussion-on-Treatment-Options-for-Atopic-Dermatitis-Patients-With-an-Inadequate-Response-to-Dupilumab.html
https://www.globenewswire.com/news-release/2024/04/24/2868471/0/en/ASLAN-Pharmaceuticals-Announces-Late-Breaking-Abstract-on-Eblasakimab-in-COPD-Accepted-for-Presentation-at-the-American-Thoracic-Society-International-Conference.html
https://www.globenewswire.com/news-release/2024/04/22/2866887/0/en/ASLAN-Pharmaceuticals-Announces-Positive-Interim-Results-From-Phase-2-Study-of-Eblasakimab-in-Dupilumab-Experienced-Atopic-Dermatitis-Patients.html
https://www.globenewswire.com/news-release/2024/04/19/2866393/0/en/ASLAN-Pharmaceuticals-Announces-Receipt-of-Nasdaq-Notice.html
https://www.globenewswire.com/news-release/2024/04/12/2862146/0/en/ASLAN-Pharmaceuticals-Reports-Fourth-Quarter-and-Full-Year-2023-Financial-Results-and-Provides-Corporate-Update.html